These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 11868523)
61. Choosing between warfarin (Coumadin) and aspirin therapy for patients with atrial fibrillation. Ebell MH Am Fam Physician; 2005 Jun; 71(12):2348-50. PubMed ID: 15999873 [No Abstract] [Full Text] [Related]
62. Effect of access to anticoagulation management services on warfarin use in patients with atrial fibrillation. Burkiewicz JS Pharmacotherapy; 2005 Aug; 25(8):1062-7. PubMed ID: 16207096 [TBL] [Abstract][Full Text] [Related]
64. Atrial fibrillation in the elderly. Fang MC; Chen J; Rich MW Am J Med; 2007 Jun; 120(6):481-7. PubMed ID: 17524745 [TBL] [Abstract][Full Text] [Related]
65. [Analysis of a circulating anticoagulant in the course of treatment with an antivitamin K. Importance in a febrile patient]. Henrionnet A; Béchade D; Algayres JP; Daly JP Presse Med; 2000 Mar; 29(10):542. PubMed ID: 10761521 [No Abstract] [Full Text] [Related]
66. Which patients with atrial fibrillation do not need anticoagulation therapy with warfarin? Guthmann RA Am Fam Physician; 2004 Sep; 70(5):917-8. PubMed ID: 15368730 [No Abstract] [Full Text] [Related]
67. Bleeding rates in elderly patients on vitamin K antagonist therapy for nonvalvular atrial fibrillation. Tay KH; Lip GY; Lane DA Blood Coagul Fibrinolysis; 2009 Jul; 20(5):392-3. PubMed ID: 19542940 [No Abstract] [Full Text] [Related]
68. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study. Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184 [TBL] [Abstract][Full Text] [Related]
69. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?]. Tandoğan I Anadolu Kardiyol Derg; 2007 Jun; 7(2):216; author reply 218-9. PubMed ID: 17513230 [No Abstract] [Full Text] [Related]
70. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?]. Kiraç FS Anadolu Kardiyol Derg; 2007 Jun; 7(2):214-5; author reply 218-9. PubMed ID: 17513229 [No Abstract] [Full Text] [Related]
71. [Quality of life of patients given pharmacological treatment for atrial fibrillation]. Engelmann MD; Godtfredsen J Ugeskr Laeger; 2004 Aug; 166(34):2877-82. PubMed ID: 15449523 [No Abstract] [Full Text] [Related]
74. Between the Devil and the Deep Blue Sea--balancing the risks and potential benefits of warfarin for older people with atrial fibrillation. Morgan SV Age Ageing; 2004 Nov; 33(6):544-7. PubMed ID: 15501835 [No Abstract] [Full Text] [Related]
75. Atrial fibrillation: more help for the most common arrhythmia. ; JAAPA; 2007 May; 20(5):18, 21. PubMed ID: 17546939 [No Abstract] [Full Text] [Related]
76. Drugs for atrial fibrillation. Digoxin comes from Digitalis lanata. Hollman A BMJ; 1996 Apr; 312(7035):912. PubMed ID: 8611904 [No Abstract] [Full Text] [Related]
77. Is Digoxin Use Safe in Atrial Fibrillation? A Review of Contemporary Studies. Hubert BD; Kido K S D Med; 2016 Jul; 69(7):322-323. PubMed ID: 28806021 [No Abstract] [Full Text] [Related]
78. Digoxin is linked to raised risk of death in patients with atrial fibrillation. Wise J BMJ; 2015 May; 350():h2387. PubMed ID: 25948109 [No Abstract] [Full Text] [Related]
79. Evidence-based medicine and digoxin. Wooten JM South Med J; 2013 Jun; 106(6):381-2. PubMed ID: 23736183 [No Abstract] [Full Text] [Related]
80. Electrophysiologic effects of digoxin in the goat model of atrial fibrillation and its clinical implications. Veloso HH J Cardiovasc Electrophysiol; 2001 Jun; 12(6):735-6. PubMed ID: 11405412 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]